GW Pharma, Insys Face Off In Cannabis Drug Space

By | August 8, 2014

Scalper1 News

Over the past 18 years, 23 U.S. states have legalized marijuana for medical uses, leading in the past few years to a rush of startups popping up like, well, weeds to cater to this new market. In June, New York became the latest state to OK medical marijuana. While many observers mention GW Pharmaceuticals (GWPH) as one of the “pot stocks,” company CEO Justin Gover disagrees with that characterization. “We started out 16 years ago with a very clear Scalper1 News

Scalper1 News